Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Arrowhead Pharma (ARWR)

Arrowhead Pharma (ARWR)
11.24 -0.11 (-0.97%) 04/17/25 [NASDAQ]
11.21 x 100 11.22 x 400
Realtime by (Cboe BZX)
11.21 x 100 11.22 x 400
Realtime 11.24 unch (unch) 04/17/25
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
10.92
Day High
11.51
Open 11.27
Previous Close 11.35 11.35
Volume 2,384,200 2,384,200
Avg Vol 2,306,895 2,306,895
Stochastic %K 52.65% 52.65%
Weighted Alpha -63.95 -63.95
5-Day Change +0.13 (+1.17%) +0.13 (+1.17%)
52-Week Range 9.57 - 30.41 9.57 - 30.41
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,543,443
  • Shares Outstanding, K 137,317
  • Annual Sales, $ 3,550 K
  • Annual Income, $ -599,490 K
  • EBIT $ -626 M
  • EBITDA $ -611 M
  • 60-Month Beta 0.99
  • Price/Sales 438.90
  • Price/Cash Flow N/A
  • Price/Book 25.32

Options Overview Details

View History
  • Implied Volatility 89.14% ( +3.47%)
  • Historical Volatility 94.42%
  • IV Percentile 96%
  • IV Rank 67.53%
  • IV High 118.81% on 04/08/25
  • IV Low 27.43% on 09/20/24
  • Put/Call Vol Ratio 0.04
  • Today's Volume 404
  • Volume Avg (30-Day) 641
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 17,028
  • Open Int (30-Day) 15,831

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.06
  • Number of Estimates 8
  • High Estimate 2.69
  • Low Estimate -1.30
  • Prior Year -1.02
  • Growth Rate Est. (year over year) +94.12%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.57 +17.45%
on 04/07/25
Period Open: 15.60
15.72 -28.50%
on 03/20/25
-4.36 (-27.95%)
since 03/17/25
3-Month
9.57 +17.45%
on 04/07/25
Period Open: 19.56
21.84 -48.53%
on 02/07/25
-8.32 (-42.54%)
since 01/17/25
52-Week
9.57 +17.45%
on 04/07/25
Period Open: 22.53
30.41 -63.04%
on 07/16/24
-11.29 (-50.11%)
since 04/17/24

Most Recent Stories

More News
Arrowhead Research: Fiscal Q1 Earnings Snapshot

Arrowhead Research: Fiscal Q1 Earnings Snapshot

ARWR : 11.24 (-0.97%)
Arrowhead, Sarepta Stocks Rise Despite Price-Target Cuts Post $1B Licensing Deal: Retail Buzz Strong

Piper reduced Sarepta’s price target to $182 from $200, highlighting the partnership’s near-term financial impact.

ARWR : 11.24 (-0.97%)
SRPT : 53.79 (-0.28%)
Arrowhead Pharma Stock Soars Pre-Market On $825M Sarepta Licensing Deal: Retail Activity Hits Year-High

The global licensing deal includes $500 million in cash and $325 million in equity, at a 35% premium upon closing.

ARWR : 11.24 (-0.97%)
SRPT : 53.79 (-0.28%)
IJH : 54.85 (+0.85%)
VTI : 258.75 (+0.21%)
Arrowhead Research: Fiscal Q3 Earnings Snapshot

Arrowhead Research: Fiscal Q3 Earnings Snapshot

ARWR : 11.24 (-0.97%)
Arrowhead Research: Fiscal Q2 Earnings Snapshot

Arrowhead Research: Fiscal Q2 Earnings Snapshot

ARWR : 11.24 (-0.97%)
Arrowhead Research: Fiscal Q1 Earnings Snapshot

Arrowhead Research: Fiscal Q1 Earnings Snapshot

ARWR : 11.24 (-0.97%)
Arrowhead Research: Fiscal Q3 Earnings Snapshot

Arrowhead Research: Fiscal Q3 Earnings Snapshot

ARWR : 11.24 (-0.97%)
Arrowhead Research: Fiscal Q2 Earnings Snapshot

Arrowhead Research: Fiscal Q2 Earnings Snapshot

ARWR : 11.24 (-0.97%)
Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal second quarter ended March 31, 2023. The company is hosting a conference call today, May 2, 2023, at 4:30...

ARWR : 11.24 (-0.97%)
UPS, Packaging Corp. fall, Arrowhead, Tenet rise

Stocks that traded heavily or had substantial price changes Tuesday: UPS, Packaging Corp. fall, Arrowhead, Tenet rise

ARWR : 11.24 (-0.97%)
JBLU : 3.67 (+7.15%)
CNC : 60.70 (-2.07%)
UPS : 96.43 (+2.37%)
PEP : 142.84 (+1.96%)
THC : 121.81 (+1.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes....

See More

Key Turning Points

3rd Resistance Point 12.11
2nd Resistance Point 11.81
1st Resistance Point 11.52
Last Price 11.24
1st Support Level 10.94
2nd Support Level 10.64
3rd Support Level 10.35

See More

52-Week High 30.41
Fibonacci 61.8% 22.45
Fibonacci 50% 19.99
Fibonacci 38.2% 17.53
Last Price 11.24
52-Week Low 9.57

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro